Detalhe da pesquisa
1.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Lancet Oncol
; 25(4): 439-454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547891
2.
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials.
JTO Clin Res Rep
; 3(9): 100385, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065449
3.
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study.
JTO Clin Res Rep
; 2(11): 100234, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34746886
4.
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial.
J Thorac Oncol
; 15(3): 404-415, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756496
5.
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study.
Clin Cancer Res
; 25(7): 2088-2095, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617139
6.
Necitumumab: a new option for first-line treatment of squamous cell lung cancer.
Expert Opin Drug Metab Toxicol
; 14(8): 765-772, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025476
7.
Targeting EGFR in Lung Cancer: Current Standards and Developments.
Drugs
; 78(9): 893-911, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915896
8.
Impacto psicológico del COVID-19 en los pacientes de Oncología Médica, Hemato Oncología y Oncología Radioterápica de un hospital público en España / Psychological impact of COVID-19 on Medical Oncology, Haemato-Oncology and Radiation Oncology patients at a public hospital in Spain
Psicooncología (Pozuelo de Alarcón)
; 20(2): 305-328, 26 oct. 2023. ilus, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-226868
9.
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
J Clin Oncol
; 35(22): 2490-2498, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475456
10.
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.
Clin Transl Oncol
; 11(7): 446-54, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19574202